BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1013 related articles for article (PubMed ID: 26402105)

  • 1. miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy.
    Karnati HK; Panigrahi MK; Gutti RK; Greig NH; Tamargo IA
    J Alzheimers Dis; 2015; 48(3):563-80. PubMed ID: 26402105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNAs and Neurodegenerative Diseases.
    Qiu L; Tan EK; Zeng L
    Adv Exp Med Biol; 2015; 888():85-105. PubMed ID: 26663180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
    Duarte FV; Palmeira CM; Rolo AP
    Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases.
    Tan L; Yu JT; Tan L
    Mol Neurobiol; 2015; 51(3):1249-62. PubMed ID: 24973986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay of RNA-Binding Proteins and microRNAs in Neurodegenerative Diseases.
    Kinoshita C; Kubota N; Aoyama K
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases.
    Nguyen TPN; Kumar M; Fedele E; Bonanno G; Bonifacino T
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of microRNAs in neurodegenerative diseases: a review.
    Li S; Lei Z; Sun T
    Cell Biol Toxicol; 2023 Feb; 39(1):53-83. PubMed ID: 36125599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature.
    Redenšek Trampuž S; Vogrinc D; Goričar K; Dolžan V
    Front Mol Neurosci; 2023; 16():1123955. PubMed ID: 37008787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design.
    Sehgal SA; Hammad MA; Tahir RA; Akram HN; Ahmad F
    Curr Neuropharmacol; 2018; 16(6):649-663. PubMed ID: 29542412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA dysregulation in neurodegenerative diseases: A systematic review.
    Juźwik CA; S Drake S; Zhang Y; Paradis-Isler N; Sylvester A; Amar-Zifkin A; Douglas C; Morquette B; Moore CS; Fournier AE
    Prog Neurobiol; 2019 Nov; 182():101664. PubMed ID: 31356849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Status of microRNA-Based Therapeutic Approaches in Neurodegenerative Disorders.
    Paul S; Bravo Vázquez LA; Pérez Uribe S; Roxana Reyes-Pérez P; Sharma A
    Cells; 2020 Jul; 9(7):. PubMed ID: 32679881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA: Basic concepts and implications for regeneration and repair of neurodegenerative diseases.
    Saraiva C; Esteves M; Bernardino L
    Biochem Pharmacol; 2017 Oct; 141():118-131. PubMed ID: 28709951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated microRNAs in neurodegenerative disorders.
    Lau P; de Strooper B
    Semin Cell Dev Biol; 2010 Sep; 21(7):768-73. PubMed ID: 20080199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNAs as biomarkers of neurodegenerative disorders.
    Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A
    Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Dysregulated microRNA Biogenesis Machinery and microRNA Sorting on Neurodegenerative Diseases.
    Weng YT; Chang YM; Chern Y
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs Dysregulation and Mitochondrial Dysfunction in Neurodegenerative Diseases.
    Catanesi M; d'Angelo M; Tupone MG; Benedetti E; Giordano A; Castelli V; Cimini A
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relation of the Brain-Derived Neurotrophic Factor with MicroRNAs in Neurodegenerative Diseases and Ischemic Stroke.
    Eyileten C; Sharif L; Wicik Z; Jakubik D; Jarosz-Popek J; Soplinska A; Postula M; Czlonkowska A; Kaplon-Cieslicka A; Mirowska-Guzel D
    Mol Neurobiol; 2021 Jan; 58(1):329-347. PubMed ID: 32944919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
    Tan L; Yu JT; Tan L
    J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering the function and regulation of microRNAs in Alzheimer's disease and Parkinson's disease.
    Qiu L; Zhang W; Tan EK; Zeng L
    ACS Chem Neurosci; 2014 Oct; 5(10):884-94. PubMed ID: 25210999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegenerative Disorders Treatment: The MicroRNA Role.
    Ridolfi B; Abdel-Haq H
    Curr Gene Ther; 2017; 17(5):327-363. PubMed ID: 29357791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.